$FA
FIRST ADVANTAGE CORP

2024 Q2 Form 10-Q Financial Statement

#000095017024056995 Filed on May 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $184.5M $169.4M
YoY Change -0.41% -3.48%
Cost Of Revenue $92.35M $87.19M
YoY Change -0.7% -4.25%
Gross Profit $92.20M $82.22M
YoY Change -0.13% -2.65%
Gross Profit Margin 49.96% 48.53%
Selling, General & Admin $38.64M $40.66M
YoY Change 28.88% 41.77%
% of Gross Profit 41.91% 49.45%
Research & Development $13.68M $12.47M
YoY Change 8.18% -1.25%
% of Gross Profit 14.83% 15.16%
Depreciation & Amortization $15.70M $15.50M
YoY Change -5.42% -5.49%
% of Gross Profit 17.03% 18.85%
Operating Expenses $174.6M $170.1M
YoY Change 4.15% 3.6%
Operating Profit $9.903M -$726.0K
YoY Change -43.85% -106.43%
Interest Expense -$7.353M -$3.570M
YoY Change 89.17% -58.88%
% of Operating Profit -74.25%
Other Income/Expense, Net -$7.353M -$3.570M
YoY Change 89.17% -58.88%
Pretax Income $2.550M -$4.296M
YoY Change -81.45% -264.85%
Income Tax $689.0K -$1.388M
% Of Pretax Income 27.02%
Net Earnings $1.861M -$2.908M
YoY Change -80.98% -251.06%
Net Earnings / Revenue 1.01% -1.72%
Basic Earnings Per Share $0.01 -$0.02
Diluted Earnings Per Share $0.01 -$0.02
COMMON SHARES
Basic Shares Outstanding 145.2M 145.2M
Diluted Shares Outstanding 145.9M 143.6M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $269.6M $246.0M
YoY Change -32.81% -38.81%
Cash & Equivalents $269.6M $245.4M
Short-Term Investments $600.0K
Other Short-Term Assets $19.79M $21.93M
YoY Change -8.4% -4.32%
Inventory
Prepaid Expenses
Receivables $130.8M $129.0M
Other Receivables $7.101M $2.568M
Total Short-Term Assets $427.2M $399.5M
YoY Change -25.28% -28.07%
LONG-TERM ASSETS
Property, Plant & Equipment $63.46M $71.35M
YoY Change -31.95% -30.93%
Goodwill $819.1M $819.6M
YoY Change 3.22% 3.32%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $8.268M $9.202M
YoY Change -21.19% -18.1%
Total Long-Term Assets $1.209B $1.232B
YoY Change -4.55% -4.63%
TOTAL ASSETS
Total Short-Term Assets $427.2M $399.5M
Total Long-Term Assets $1.209B $1.232B
Total Assets $1.636B $1.632B
YoY Change -11.0% -11.68%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $55.49M $47.96M
YoY Change 6.85% 0.99%
Accrued Expenses $20.64M $24.10M
YoY Change 31.8% 43.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $99.10M $93.20M
YoY Change 9.98% 9.7%
LONG-TERM LIABILITIES
Long-Term Debt $559.4M $558.9M
YoY Change 0.32% 0.32%
Other Long-Term Liabilities $2.697M $2.826M
YoY Change -10.46% -10.85%
Total Long-Term Liabilities $562.1M $561.7M
YoY Change 0.26% 0.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $99.10M $93.20M
Total Long-Term Liabilities $562.1M $561.7M
Total Liabilities $722.6M $724.2M
YoY Change -2.87% -2.18%
SHAREHOLDERS EQUITY
Retained Earnings -$50.59M -$52.45M
YoY Change -26.15% 2.94%
Common Stock $988.1M $983.1M
YoY Change -16.53% -16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $913.3M $907.7M
YoY Change
Total Liabilities & Shareholders Equity $1.636B $1.632B
YoY Change -11.0% -11.68%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $1.861M -$2.908M
YoY Change -80.98% -251.06%
Depreciation, Depletion And Amortization $15.70M $15.50M
YoY Change -5.42% -5.49%
Cash From Operating Activities $32.04M $38.33M
YoY Change -3.26% -0.7%
INVESTING ACTIVITIES
Capital Expenditures $7.408M $321.0K
YoY Change 5.47% 664.29%
Acquisitions
YoY Change
Other Investing Activities $627.0K $575.0K
YoY Change -397.16% -3933.33%
Cash From Investing Activities -$6.781M -$7.031M
YoY Change -6.28% 15.58%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -476.0K 689.0K
YoY Change -98.23% -102.85%
NET CHANGE
Cash From Operating Activities 32.04M 38.33M
Cash From Investing Activities -6.781M -7.031M
Cash From Financing Activities -476.0K 689.0K
Net Change In Cash 24.79M 31.66M
YoY Change -2756.59% 272.46%
FREE CASH FLOW
Cash From Operating Activities $32.04M $38.33M
Capital Expenditures $7.408M $321.0K
Free Cash Flow $24.64M $38.01M
YoY Change -5.61% -1.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001210677
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-31666
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
First Advantage Corporation
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
84-3884690
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Concourse Parkway NE
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Atlanta
CY2024Q1 dei Entity Address Country
EntityAddressCountry
GA
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30328
CY2024Q1 dei City Area Code
CityAreaCode
888
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
314-9761
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2024Q1 dei Trading Symbol
TradingSymbol
FA
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
145197595
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
245436000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
213774000
CY2024Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
135000
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
138000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
600000
CY2023Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
893000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1036000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
129011000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
142690000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21795000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13426000
CY2024Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
2568000
CY2023Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
3710000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
399545000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
373738000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71352000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79441000
CY2024Q1 us-gaap Goodwill
Goodwill
819633000
CY2023Q4 us-gaap Goodwill
Goodwill
820654000
CY2024Q1 fa Trade Name Net
TradeNameNet
64370000
CY2023Q4 fa Trade Name Net
TradeNameNet
66229000
CY2024Q1 fa Customer Lists Net
CustomerListsNet
262876000
CY2023Q4 fa Customer Lists Net
CustomerListsNet
275528000
CY2024Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2138000
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
2257000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2797000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2786000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9202000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10021000
CY2024Q1 us-gaap Assets
Assets
1631913000
CY2023Q4 us-gaap Assets
Assets
1630654000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
47956000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
47024000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12742000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16379000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
24102000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16162000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3367000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3354000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
2988000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
264000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2043000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1856000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
93198000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
85039000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5815000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6268000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558909000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558456000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
63604000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
71274000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5632000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5931000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2826000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3221000
CY2024Q1 us-gaap Liabilities
Liabilities
724169000
CY2023Q4 us-gaap Liabilities
Liabilities
723921000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
145195030
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145195030
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
145074802
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
145074802
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
145000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
145000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
982982000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
977290000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-52453000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-49545000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-22930000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21157000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
907744000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
906733000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1631913000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1630654000
CY2024Q1 us-gaap Revenues
Revenues
169416000
CY2023Q1 us-gaap Revenues
Revenues
175520000
CY2024Q1 fa Cost Of Services Excluding Depreciation And Amortization
CostOfServicesExcludingDepreciationAndAmortization
87192000
CY2023Q1 fa Cost Of Services Excluding Depreciation And Amortization
CostOfServicesExcludingDepreciationAndAmortization
91061000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12466000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12624000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
40662000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28682000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29822000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31866000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
170142000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
164233000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-726000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11287000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3570000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-8681000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3570000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8681000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4296000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2606000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1388000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
681000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2908000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1773000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
869000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4681000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2794000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2908000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143591713
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145862562
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143591713
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147031866
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2908000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29822000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31866000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
453000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
461000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-112000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-40000
CY2024Q1 fa Deferred Taxes
DeferredTaxes
-7808000
CY2023Q1 fa Deferred Taxes
DeferredTaxes
-2144000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4751000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2058000
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
10000
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-1222000
CY2024Q1 fa Gain Loss Due To Change In Fair Value Of Interest Rate Swaps
GainLossDueToChangeInFairValueOfInterestRateSwaps
7045000
CY2023Q1 fa Gain Loss Due To Change In Fair Value Of Interest Rate Swaps
GainLossDueToChangeInFairValueOfInterestRateSwaps
-1879000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13736000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15980000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3345000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2933000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
468000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-7618000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6608000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-11828000
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
185000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
209000
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-328000
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-110000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-11000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
980000
CY2024Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
3863000
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
836000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38329000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38599000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
321000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42000
CY2024Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6135000
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
6056000
CY2024Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
575000
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-15000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7031000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6083000
CY2024Q1 fa Cash Dividends Paid
CashDividendsPaid
12000
CY2023Q1 fa Cash Dividends Paid
CashDividendsPaid
0
CY2024Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
0
CY2023Q1 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
25266000
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
976000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
1399000
CY2024Q1 fa Payments On Deferred Purchase Agreements
PaymentsOnDeferredPurchaseAgreements
234000
CY2023Q1 fa Payments On Deferred Purchase Agreements
PaymentsOnDeferredPurchaseAgreements
234000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
37000
CY2024Q1 fa Net Settlement Of Share Based Compensation Plan Awards
NetSettlementOfShareBasedCompensationPlanAwards
-41000
CY2023Q1 fa Net Settlement Of Share Based Compensation Plan Awards
NetSettlementOfShareBasedCompensationPlanAwards
-25000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
689000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24163000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-328000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
31659000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8500000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
213912000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
391796000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
245571000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400296000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2510000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2049000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
11954000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
10625000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
585000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
275000
CY2024Q1 fa Non Cash Property And Equipment Additions
NonCashPropertyAndEquipmentAdditions
540000
CY2023Q1 fa Non Cash Property And Equipment Additions
NonCashPropertyAndEquipmentAdditions
0
CY2024Q1 fa Excise Taxes On Share Repurchases Incurred But Not Paid
ExciseTaxesOnShareRepurchasesIncurredButNotPaid
0
CY2023Q1 fa Excise Taxes On Share Repurchases Incurred But Not Paid
ExciseTaxesOnShareRepurchasesIncurredButNotPaid
252000
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
906733000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4751000
CY2024Q1 fa Forfeitures Of Previously Declared Cash Dividends
ForfeituresOfPreviouslyDeclaredCashDividends
6000
CY2024Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
976000
CY2024Q1 fa Additional Paid In Capital Withheld For Tax Obligations And Net Settlement Of Stock Option Exercise
AdditionalPaidInCapitalWithheldForTaxObligationsAndNetSettlementOfStockOptionExercise
-41000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1773000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2908000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
907744000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1126618000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2058000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
25517000
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1399000
CY2023Q1 fa Additional Paid In Capital Withheld For Tax Obligations And Net Settlement Of Stock Option Exercise
AdditionalPaidInCapitalWithheldForTaxObligationsAndNetSettlementOfStockOptionExercise
-25000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
869000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1107327000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> — The preparation of the condensed consolidated financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Changes in these estimates and assumptions may have a material impact on the condensed consolidated financial statements and accompanying notes.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Significant estimates, judgments, and assumptions, include, but are not limited to, the determination of the fair value and useful lives of assets acquired and liabilities assumed through business combinations, goodwill impairment, revenue recognition, capitalized software, assumptions used for purposes of determining share-based compensation, and income tax liabilities and assets. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates.</span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Concentrations of Credit Risk — </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Financial instruments which potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. Cash is deposited with major financial institutions and, at times, such balances with each financial institution may be in excess of insured limits. The Company has not experienced, and does not anticipate, any losses with respect to its cash deposits. Accounts receivable represent credit granted to customers for services provided. The Company performs ongoing credit evaluations of its customers’ financial condition and generally does not require collateral on accounts receivable. </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company had </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">one</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> customer which represented approximately </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">11</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% of its consolidated revenues during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three months ended March 31, 2024</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. The Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t have any customers which represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or more of its consolidated revenues during the </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">three months ended March 31, 2023</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">. Additionally, the Company did </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">no</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">t have any customers which represented </span><span style="font-size:10pt;font-family:Times New Roman;color:#000000;white-space:pre-wrap;min-width:fit-content;">10</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">% or more of its consolidated accounts receivable, net for any period presented.</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:9pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Company has entered into interest rate derivative agreements with a counterparty bank to reduce its exposure to interest rate volatility. The Company has determined the counterparty bank to be a high credit quality institution. The Company does not enter into financial instruments for trading or speculative purposes.</span></p>
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355369000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
348060000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
284017000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
268619000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
71352000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
79441000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15500000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16400000
CY2023Q4 us-gaap Goodwill
Goodwill
820654000
CY2024Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-25000
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-996000
CY2024Q1 us-gaap Goodwill
Goodwill
819633000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
618151000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
288767000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
329384000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
618826000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
274812000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
344014000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
14300000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
15400000
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5815000
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6268000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558909000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558456000
CY2024Q1 fa Description Of Borrowing Capacity Not Subject To Net Leverage Ratio Covenant
DescriptionOfBorrowingCapacityNotSubjectToNetLeverageRatioCovenant
In the event the Company’s outstanding indebtedness under the Revolver exceeds 35% of the aggregate principal amount of the revolving commitments then in effect, it is required to maintain a consolidated first lien leverage ratio no greater than 7.75 to 1.00.
CY2024Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
150000000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.323
CY2024Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.261
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6700000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
4800000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2000000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1900000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4751000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2058000
CY2023Q2 fa Impact Of Divided To Stock Option Awards And Espp Purchases
ImpactOfDividedToStockOptionAwardsAndESPPPurchases
1.5
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
36400000
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P1Y3M18D
CY2024Q1 fa Employee Stock Purchase Plan Percent
EmployeeStockPurchasePlanPercent
0.15
CY2024Q1 fa Employee Stock Purchase Plan Expenses
EmployeeStockPurchasePlanExpenses
200000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 fa Indemnity Liability
IndemnityLiability
4700000
CY2023Q4 fa Indemnity Liability
IndemnityLiability
5200000
CY2024Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.01
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.01
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2908000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1925000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
143591713
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
145862562
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1169304
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143591713
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147031866
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3287852
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2913298
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
169416000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
175520000
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q1 fa Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q1 fa Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-24-056995-index-headers.html Edgar Link pending
0000950170-24-056995-index.html Edgar Link pending
0000950170-24-056995.txt Edgar Link pending
0000950170-24-056995-xbrl.zip Edgar Link pending
fa-20240331.htm Edgar Link pending
fa-20240331.xsd Edgar Link pending
fa-ex2_2.htm Edgar Link pending
fa-ex31_1.htm Edgar Link pending
fa-ex31_2.htm Edgar Link pending
fa-ex32_1.htm Edgar Link pending
fa-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
fa-20240331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending